-transparent.png){kind=logo}
Lecithin:cholesterol acyltransferase (LCAT) deficiency is a rare familial disease inherited in an autosomal recessive pattern. It is characterized by a combination of plasma lipoprotein, corneal, erythrocyte and, in most patients, renal changes. The corneal changes consist of scattered stromal dots that are lipid deposits. Their composition is unique and suggests an intrinsic corneal metabolic defect. The corneal clouding is usually asymptomatic. Patients with the condition must be followed closely because renal failure may develop. We describe a patient with LCAT deficiency.
Related Publications
L Bellan, and
F Mikelberg, and
J Frohlich
May 2015,
Clinical biochemistry,
L Bellan, and
F Mikelberg, and
J Frohlich
January 1980,
Annals of the New York Academy of Sciences,
L Bellan, and
F Mikelberg, and
J Frohlich
January 2016,
Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia,
L Bellan, and
F Mikelberg, and
J Frohlich
January 1974,
Scandinavian journal of clinical and laboratory investigation. Supplementum,
L Bellan, and
F Mikelberg, and
J Frohlich
January 1978,
Scandinavian journal of clinical and laboratory investigation. Supplementum,
L Bellan, and
F Mikelberg, and
J Frohlich
June 2012,
Atherosclerosis,
L Bellan, and
F Mikelberg, and
J Frohlich
March 1985,
Journal of lipid research,
L Bellan, and
F Mikelberg, and
J Frohlich
January 1974,
Scandinavian journal of clinical and laboratory investigation. Supplementum,
L Bellan, and
F Mikelberg, and
J Frohlich
January 1981,
Acta medica Scandinavica,
L Bellan, and
F Mikelberg, and
J Frohlich
February 1988,
Biochimica et biophysica acta,
